Deep Vein Thrombosis Market Projected to Ascend to $1.26 billion by 2028: A Fresh Global Market Report Unveiled Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Deep Vein Thrombosis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. An extensive global market report on...

Regulatory Authorities in China and Japan Approve Clinical Trials for Anthos Therapeutics’ Dual-Acting Factor XI/XIa Inhibitor Abelacimab Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated Approximately 63% of Cancer Patients in China...

Heparin Market Revenue worth $5.7 Billion by 2028, Says Global Market Insights Inc. Selbyville, Delaware, March 02, 2022 (GLOBE NEWSWIRE) -- Global heparin market value is projected to reach USD 5.7 billion by 2028, according to a new research report by Global Market Insights...

Venous Thromboembolism Treatment Market In North America Is Expected To Represent Significant Income Share In The Worldwide: Acumen Research And Consulting Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Venous Thromboembolism Treatment Market - Global Industry Analysis, Market Size,...

Heparin Market in the U.S. to Hit USD 1 Bn by 2026: Global Market Insights, Inc. Selbyville, Delaware, Dec. 01, 2020 (GLOBE NEWSWIRE) -- According to latest report “U.S. Heparin Market by Product (Low Molecular Weight Heparin, Unfractionated Heparin), Application (Venous...